Review
Open access
Sep 2026
Developing neoantigen cancer vaccines: where are we now?
This review examines recent advances in neoantigen cancer vaccine development, highlighting clinical progress across cancer types while discussing ongoing challenges and opportunities to enhance vaccine design, delivery, and combination immunotherapy approaches.
N. Markosyan, Robert H. Vonderheide
· Nature Communications · 1 citation